Skip to main content
Premium Trial:

Request an Annual Quote

Fluorotechnics Q2 Revenues Drop to $129K

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fluorotechnics last week reported that second-quarter revenues from customers had dropped to A$119,189 ($129,151), down from A$1.9 million ($2.1 million) a year ago.

For the quarter ended June 30, R&D expenses were sliced to A$9,425 from $264,231 a yaer ago, while SG&A spending dropped to A$1,169 from A$354,777.

Net operating cash flows came in at a loss of A$87,601, down from a loss of A$1.6 million in the second quarter of 2010.

As of June 30, the Australian fluorescence and protein detection technologies firm had A$189,278 in cash.

The company is in the midst of a restructuring effort that includes the scaling back of its operations and sale of certain of its assets. Ian Gilmour, Fluorotechnic's secretary, said in a note that the company is continuing the process "for the orderly sale of the remaining operations and assets."

He added that the company "is continuing to review new investment opportunities."

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.